Earnings History Data for Acasti Pharma, Inc. (ACST) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Acasti Pharma, Inc.
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-02-2024 | PM | ACST | Acasti Pharma | 23.00 | -0.21 | -0.30 | 0.00 | Acasti Pharma GAAP EPS of -$0.21 [2/12/2024 11:14 AM] |
2.67 | 0.22 (9.18%) |
2.50 | 0.05 (2.04%) |
1.72 - 4.20 | 62,510 | 10,000 | 1,211 | ||
| 11-08-2023 | PM | ACST | Acasti Pharma, Inc. | 107.52 | -0.34 | -0.63 | -0.60 | Acasti Pharma GAAP EPS of -$0.54 [8/11/2023 7:42 AM] |
2.37 | -0.05 (-2.07%) |
2.32 | -0.04 (-1.69%) |
2.04 - 5.94 | 5,372 | 20,000 | 3,149 | ||
| 14-02-2023 | PM | 7:00 AM ET (Feb 14) |
ACST | Acasti Pharma | 31.00 | -0.09 | -0.13 | 0.00 | Acasti Pharma GAAP EPS of -C$0.09 [2/14/2023 7:03 AM] |
0.6210 | -0.02 (-3.50%) |
0.69 | 0.04 (6.99%) |
0.34 - 1.35 | 90,503 | 110,000 | 2,076 | |
| 14-11-2022 | PM | 7:00 AM ET (Nov 14) |
ACST | Acasti Pharma, Inc. | 22.48 | -0.11 | 0.00 | 0.03 | Acasti Pharma GAAP EPS of -$0.11 [11/14/2022 7:15 AM] |
0.5193 | 0.02 (3.24%) |
0.53 | 0.03 (5.96%) |
0.47 - 1.79 | 185,320 | 70,000 | 2,092 | |
| 11-08-2022 | PM | 8:00 AM ET (Aug 11) |
ACST | Acasti Pharma, Inc. | 38.24 | -0.10 | 0.00 | -0.08 | Acasti Pharma GAAP EPS of -$0.10 [8/11/2022 7:08 AM] |
0.9065 | 0.02 (2.08%) |
0.92 | 0.03 (3.60%) |
0.80 - 3.86 | 97,330 | 90,000 | 22,399 | |
| 21-06-2022 | PM | 7:00 AM ET (Jun 21) |
ACST | Acasti Pharma | 40.00 | -0.04 | -0.13 | 0.00 | Acasti Pharma reports GAAP EPS of $0.27 for FY2022 [6/21/2022 8:10 AM] |
0.94 | 0.01 (1.08%) |
0.95 | 0.02 (2.15%) |
0.82 - 5.44 | 165,230 | 100,000 | 1,096 | |
| 14-02-2022 | PM | 7:00 AM ET (Feb 14) |
ACST | Acasti Pharma, Inc. | 54.47 | -0.09 | -0.08 | -0.16 | Acasti Pharma GAAP EPS of -$0.09 misses by $0.01 [2/14/2022 7:00 AM] |
1.21 | 0.07 (6.14%) |
1.18 | 0.04 (3.51%) |
1.04 - 9.12 | 176,215 | 240,000 | 14,484 | |
| 10-11-2021 | PM | 6:55 AM ET (Nov 10) |
ACST | Acasti Pharma, Inc. | 75.29 | 0.03 | 0.00 | -0.40 | Acasti Pharma EPS beats by $0.60 [11/10/2021 7:20 AM] |
1.66 | -0.03 (-1.78%) |
1.73 | 0.04 (2.37%) |
1.47 - 9.76 | 361,192 | 380,000 | 23,682 | |